Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Offer Opening Public Announcement under Regulations 18(7) of The Securities and Exchange Board ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Saffron Capital Advisors, acting as manager to the open offer, has submitted the Offer Opening Public Announcement to BSE for Pharmaids Pharmaceuticals Ltd. The acquirer Shankarappa Nagaraja Vinaya Babu, along with Person Acting in Concert Tumkur Trade Center Pvt Ltd, is offering to buy up to 91,69,632 equity shares (face value Rs 10 each) at Rs 62.15 per share, aggregating to approximately Rs 56.99 crore. The offer is being made under SEBI (SAST) Regulations, 2011. The announcement was published on August 1, 2025 in Financial Express (English), Jansatta (Hindi), Udaykala (Kannada, Bangalore edition), and Navshakti (Marathi, Mumbai edition).
Public shareholders of Pharmaids Pharmaceuticals can tender their shares at Rs 62.15 each during the open offer window, providing an exit opportunity at a defined price. This signals a change in control or significant stake acquisition, which may influence the stock's trading price around the offer period.